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Abstract 
Recent work using micro-Fourier transform infrared (FTIR) imaging has revealed that a lipid-rich layer 
surrounds many plaques in post-mortem Alzheimer’s brain. However, the origin of this lipid layer is 
not known, nor is its role in the pathogenesis of Alzheimer’s disease (AD). Here, we studied the 
biochemistry of plaques in situ using a model of AD. We combined FTIR, Raman and 
immunofluorescence images, showing that astrocyte processes co-localise with the lipid-ring 
surrounding many plaques. We used FTIR imaging to rapidly measure chemical signatures of plaques 
over large fields of view, and selected plaques for higher resolution analysis with Raman. Raman maps 
showed similar lipid-rings and dense protein cores as in FTIR images, but also revealed cell bodies. We 
confirmed the presence of plaques using amylo-glo staining, and measured astrocytes using 
immunohistochemistry, revealing astrocyte co-localisation with lipid-rings. This work is important 
because it correlates biochemically changes surrounding the plaque with the biological process of 
astrogliosis. 
 
 
Introduction 
 
Alzheimer’s disease (AD) is a progressive neurodegenerative disease and the most common form of 
dementia worldwide. There are currently 47 million affected people, a number that is predicted to 
double every 20 years 1, hence posing a significant burden in healthcare management of an ageing 
population. Amyloidopathy is a major hallmark of AD and consists in the abnormal accumulation in 
the brain parenchyma of the amyloid- peptide (A), an aggregation-prone protein fragment of 40–
42 amino acids produced by the cleavage of amyloid precursor protein (APP). The monomer form of 
the A peptide is thought to physiologically exist as a soluble molecule in the brain; in some cases, Aβ 
monomers can progressively aggregate forming oligomers until they eventually precipitate into 
insoluble fibrils and finally nucleating to form insoluble plaques 2, 3. Soluble oligomers have increasingly 
being recognised as the neurotoxic form of A that can also be found, as a marker of the disease, in 
blood and cerebrospinal fluid 4-6. The A peptide is the main but not the only component of amyloid 
plaques. The oligomeric composition of the deposits determines the biological effect and plausibly the 
clinical outcome of β-amyloidosis 7. Neurotoxicity seems to arise from early accumulation of soluble 
oligomeric species, rather than insoluble fibrils (with prevalent antiparallel -strands 8) or larger 
plaque formations. 
 
The lack of a diagnostic tool for AD in vivo has prompted early attempts of applying vibrational 
spectroscopy techniques to investigate the molecularity and structure of A plaques in the brain of 
both humans and mouse models of AD 9. Intriguingly, these studies have revealed that many plaques 
contain a lipid-rich layer surrounding the plaque. Dense core plaques in a (TgCRND8) transgenic mouse 
brain are composed of intermolecular -sheet structures of the A peptide, with significant increase 
in lipids around the core 10. Though the origin of this lipid layer has been the focus of several studies, 
including some based on multiphoton microscopy, a definitive hypothesis and mechanism of whole 
plaque formation is still lacking. 
 
Significant advances in FTIR spectroscopic imaging of AD brain have been brought about by Gough 
and co-workers, showing that it is possible to achieve enhanced spatial resolution in focal plane array 
(FPA) detection of plaques using synchrotron light source 10-12 or high magnification optics 13. FTIR 
imaging has also been applied to probe early conformational changes of A and APP in AD mouse 
brain (Tg19959) that precede plaque formation and localize to synaptic terminals 14. Previous work 
using Raman microscopy 9, 15 has focused on the detection and chemical characterization of A 
deposits, but there is still lack of a combined use of Raman and FTIR imaging in order to obtain detailed 
information about the structure and chemical composition of plaques within the brain. 
 
An in-depth investigation of the molecular species involved in the mechanism of A plaque formation 
is the first step to unravel the pathophysiology of this complex disease. The aim of this work was to 
investigate the chemical and structural character associated with the distribution of specific 
compounds within amyloid plaques. Although some hypotheses have previously been made, no 
definitive conclusion around the origin of the lipid-rich ring surrounding the plaque core has yet been 
made. We clarified this for the first time in the present work using chemical imaging and correlative 
immunofluorescence imaging of plaques. 
 
In this work, we used a TASTPM transgenic mouse model of AD characterized by A overexpression. 
TASTPM mice carry a double mutation on the APP and one single mutation on the presenilin-1 gene 
resulting in severe accumulation of amyloid plaques and cognitive impairment by the sixth month of 
age 16, 17. Using fixed brain histological sections obtained from TASTPM mice we analysed the A 
deposits within the hippocampus, a brain area that is involved in memory encoding and is severely 
affected in AD. Here, we provide evidence that plaque-surrounding astrocytic processes correlate with 
the presence of elevated lipid signals in the region surrounding the plaque core. 
 
 
Results 
 
FTIR and immunofluorescence. Figure 1a shows a photomicrograph of a transgenic (TG) mouse brain 
section, whereby the CA1 subfield of the hippocampus is easily recognizable because of the shell-
shaped curvature of the tissue. Amyloid plaques can be visually identified as dark spots under white 
light due to light scattering. 
Micro-transmission FTIR images from this location are presented in figure 1b–f. Each chemical image 
represents a plot of the integrated absorbance of a specific band in the IR spectrum across the area 
imaged by the focal plane array (FPA) detector. 
 
 
 
 
Figure 1. (Top panel) Visible and FTIR images of a section of transgenic mouse brain containing the hippocampus. (a) 
Photomicrograph. Acronyms, which identify specific regions of the hippocampal CA1 region, are defined in the text. The FTIR 
images refer to the distribution of the integrated absorbance of (b) lipid (C=O)ester (1761–1722 cm–1), (c) (CH) (3003–2805 
cm–1), (d) amide I (1716–1595 cm–1), (e) amide II (1593–1483 cm–1), and (f) intermolecular -sheet structure (1640–1620 cm–
1 with baseline at 1716–1595 cm–1). (Bottom panel) Spectra, visible and FTIR images of an amyloid plaque extracted from 
the same measurement. The FTIR images refer to the distribution of the integrated absorbance of (k) amide II and (l) lipid 
(C=O)ester bands. The lipid-ring can be clearly seen in (l). Cursors indicate the same pixel in correspondence of the plaque 
core. Black dots in (k) indicate the pixels from which FTIR spectra were selected along a horizontal line from the core through 
to the margin of the plaque. Spectra are colour coded to match the colours in image (k). (g) Main absorption bands are 
assigned to NH stretching (amide A and B; 3600–3000 cm–1), CH stretching (3000–2800 cm–1), lipid (C=O)ester (1761–1722 
cm–1), amide I (1718–1600 cm–1), amide II (1590–1480 cm–1), phosphate and amide III (1270–1180 cm–1), phosphate and 
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sugars (1096–1016 cm–1). Bold labels refer essentially to lipid bands. (h) FTIR spectra normalized to the maximum of NH 
stretching and amide I bands for the regions at high and low wavenumbers, respectively. Note that no baseline correction 
was applied to the spectra. (i) Arrow indicates the spectral change, i.e. a decrease in intermolecular -sheet structures, going 
from the core to the periphery of the plaque, corresponding to the black dots in (k). 
 
Protein distribution images (figure 1d–f) show the prevalence of A plaques identified as red spots in 
this region. Red in the pseudo-colour images corresponds to high absorbance hence high 
concentration of the molecular species, whilst blue corresponds to low absorbance hence low 
concentration. Figure 1f is an image based on the amide I sub-peak at 1628 cm–1, which is distinctive 
for intermolecular -sheet structures 18. Images of the lipids (figure 1b,c), based on the ester carbonyl 
stretching ( (C=O)ester ) at 1735 cm–1 and CH stretching ( (CH) ) in the range 3003–2805 cm–1 obtained 
from the same measurement, show lipids as green regions mostly co-localized with the plaques. The 
blue arc in figure 1b denotes the Stratum Pyramidale (SP), which is the cell body layer, where lipids 
are less abundant. Stratum Oriens (SO), Stratum Radiatum (SR) and Stratum Lacunosum Moleculare 
(SLM), all containing non-myelinated components such as axonic and dendritic processes (from CA1 
pyramidal neurons, apical and basal dendrites, and other CA1 inter-neuronal processes) and sparse 
cell bodies, have intermediate lipid content and are shown as cyan. The red arc in figure 1b,c identifies 
a layer that corresponds to the alveus, containing myelinated axons (myelin electrically insulates axons 
and speeds neural conduction) projecting from the CA1 subfield of the hippocampus to other brain 
areas. 
 
The distinctive structure of A deposits is clearly visualized in figures 1k,l, which present the dense 
core plaque identified by the crosshair cursor in figure 1j. The distributions of the protein and lipid 
ester bands show a dense core that is rich in polypeptides (figure 1k) and a ring-shaped region around 
the core rich in lipids (figure 1l). Spectra selected from different regions of the plaque show (figure 1g) 
a gradient of absorbance, which decreases from the core through to the periphery due to a decrease 
in thickness of the tissue section and/or in tissue density. The corresponding normalized spectra 
(figure 1h) show relevant differences between profiles: the plaque core spectrum (red line) has a 
doublet bandshape for the amide I mode, with a maximum at 1651 cm–1, generally assigned to -helix, 
and a shoulder at 1628 cm–1, associated with -sheet 10; conversely, the periphery of the plaque has a 
single broad band at 1654 cm–1. The observed spectral change indicates a gradual decrease of protein 
signals due to the intermolecular -sheets (at 1628 cm–1), amide II (figure 1i) and the amyloid band 
(plausibly due to CH deformation, at 1404 cm–1 12) accompanied by an increase of lipid bands (CH 
stretching at 2923 and 2852 cm–1, which are due to the asymmetric and symmetric stretching 
vibrations of lipid acyl CH2 groups, respectively; (C=O)ester at 1738 cm–1) when going from the core 
through to the periphery of the plaque. To analyse these variations, difference spectra were calculated 
(see below). Figure 1 shows representative images of FTIR-visualised plaques - more samples from 
different mice and more sections from the same mice can be found in the Supplementary Information 
(figure SI-1). 
 
To confirm that the plaques identified with FTIR imaging were indeed genuine plaques, we compared 
the FTIR images directly with immunofluorescence imaging based on amylo-glo staining of the same 
specimen (see figure 2). Amylo-glo fluorescence assay is a consolidated “gold standard” for the 
detection and quantification of A 19. Figure 2d shows an overlay between the FTIR image (rainbow) 
and the amylo-glo staining (white). 
 
 Figure 2. Visible, FTIR and fluorescence images of a section of transgenic mouse brain containing the hippocampus. (a) 
Photomicrograph; dense core plaques appear darker than surrounding tissue. The box (black) indicates an area where a 
fluorescence image was obtained. (b) FTIR image showing the distribution of the integrated absorbance of the intermolecular 
-sheet structures in the range 1645–1622 cm–1 (baseline at 1716–1595 cm–1). (c) Fluorescence image of the section stained 
with amylo-glo for A peptide. (d) Composite image formed by overlaying the FTIR and fluorescence (white pixels) images. 
 
The hippocampi of wild type (WT) mice entirely lack plaque pathology. FTIR imaging applied to ex-
vivo hippocampal sections from WT mice (figure SI-2) reveal no occurrence of the plaque structures 
observed in TG animals. The distributions of intermolecular -sheet (figure SI-2a,d) do not present the 
focal accumulations representative of plaques observed in the TG mice brain (see e.g. figure 1f). 
Similarly, the lipid distributions (figure SI-2b,e) show no appearance of ring-shaped regions, but 
instead simply outline the normal layered anatomical structure of the hippocampus. Staining with the 
amyloid-specific probe amylo-glo did not reveal the presence of any plaque in these samples (figure 
SI-2c,f). 
 
Correlative FTIR imaging and Raman mapping. Combining Raman and infrared imaging is a powerful 
tool as FTIR can rapidly scan large fields of view so that images of plaques can be made, while Raman 
microscopy has higher spatial resolution (diffraction limited to /2NA = 0.8 m) but, in general, is a 
much slower technique restricting the number of plaques that can be analysed. To our knowledge, 
this is the first time that a side-by-side comparison of Raman with FTIR has been performed on 
individual plaques.  
 
Correlative FTIR imaging, Raman mapping and fluorescence imaging were conducted on TG and WT 
mice brain specimens. Raman microscopy revealed the presence of -pleated sheet conformation in 
the plaque core and the lipid ring around it, as shown in figure 3. 
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Figure 3. (Top and middle panels) Photomicrographs, FTIR images and Raman principal component analysis (PCA) score 
maps of a transgenic mouse brain hippocampal section. Black box in (a) indicates a specific plaque area within the whole 
tissue FTIR image. The FTIR images refer to the distribution of the integrated absorbance of the (b) amide II (1588–1482 cm–
1) and (c) lipid (C=O)ester band (1761–1722 cm–1), and of the height of the -sheet peak (at 1628 cm–1). Colour scale limits 
are (b) 15 to –1.5, (c) 1.5 to 0.5, and (d) 0.9 to –0.09. Black box in (e) denotes a 99⨉99 m2 area (same plaque as in a) where 
a Raman map was acquired using a 1.4 m step-size. Map scores were derived from PCA applied to the Raman map and refer 
to the distribution of (f) average spectrum, (g) lipid-rich envelope and (h) -sheet protein core(s) of the plaque. (Bottom 
panel) Representative FTIR spectra and Raman loading plots of a plaque. (i) Spectra extracted from a FTIR image (figure 1k) 
and normalized with respect to the amide I band peak absorbance. Amide I peak position is 1651 cm–1 for the core and 1654 
cm–1 for the ring, indicative of protein’s -helix conformation; the core spectrum has a doublet bandshape for the amide I 
mode. A difference spectrum was obtained by subtracting the ring profile from the core profile; it shows a loss of absorbance 
for the core spectrum at ca. 1738 cm–1 (lipid esters) and a gain at 1628 cm–1 (intermolecular -sheets) and 1404 cm–1 (not 
fully clarified signature of the plaque core, slightly shifted to the position found in a different mouse model 12). (j) Loading 
plots extracted from PCA applied to the Raman map (in the middle panel). PC3 corresponds to the core spectrum and 
presents the distinctive amide I symmetric peak of the -sheet conformation at 1667 cm–1, 15 whilst PC2 represents the ring, 
with resonances due to lipids (distinctive bands at 1434 (CH2 deformation) and 1123 cm–1 (C–C stretching) ) and other protein 
conformations (1648 cm–1, assigned to -helix and random coils) 20. PC1 denotes the mean spectrum of the tissue. 
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Figures 3a and e display a TG hippocampal section visualised under the FTIR microscope (15⨉ 
objective) and Raman microscope (20⨉), respectively; the latter photomicrograph shows the area 
where a Raman map of a plaque in CA1 was acquired. Figures 3b–d are portions of FTIR mosaic images 
of a plaque based on the protein (amide II), lipid ester and -sheet peak (height) distribution, 
respectively. PCA was applied to the Raman map (72⨉72 points at 1.4 m distance) and the first three 
components were analysed. PC1, which represents the average spectrum of the sample, is shown in 
figure 3f, whilst figures 3g,h are score maps of PC2 and PC3, respectively, which give the distribution 
of the lipid ring surrounding the plaque core and the -pleated sheet protein conformation – mainly 
concentrated in the core. From these images it is apparent that the higher spatial resolution of Raman 
microscopy enables a detailed analysis of the plaque structure, as shown in figure 3f–h. Multivariate 
analysis applied to all Raman datasets aided in extracting the relevant information that otherwise was 
hard to disentangle through a univariate spectral analysis. 
These results show that (1) Raman can reveal the same structures as can be seen with FTIR imaging 
(i.e. protein rich core and lipid ring), while also showing additional features such as cell bodies (figure 
4b – more discussion on this follows); (2) Raman has better resolution than FTIR and can reveal similar 
chemical structures; it is also much slower and cannot be easily applied to a large field of view, which 
is an advantage of using FTIR. 
Figure 3i illustrates representative FTIR spectra of a plaque in a TG mouse brain sample. The 
spectrum of the core presents the weakest absorbance of the lipid band (C=O stretching at 1738 cm–
1), indicating a lower lipid concentration in the core than in the ring around the plaque, in accordance 
with previous observations 21. A change in bandshape of the amide I band is clearly revealed here, the 
core spectrum showing a maximum at 1651 cm–1, which is shifted at 1654 cm–1 in the ring spectrum. 
This spectral effect may be attributed to a change in the secondary structure of the proteins in the 
two sub-regions of the plaque. At these high frequencies, absorption due to the -helix conformation 
is expected 10; a lower wavenumber position of the amide I band maximum in the core profile 
correlates with an increase of (-sheet) ordered structure for the proteins in the plaque core area, 
while less ordered peptide structures would characterize the ring. Such an effect has been previously 
reported for both the A peptide 21 and other proteins 22, 23. Here the enhancement of absorbance at 
1628 cm–1 (ordered conformation), highlighted by the difference spectrum in figure 3i, can be referred 
to the peptide’s intermolecular -sheet structures which are characteristic of the core. 
Figure 3j is a plot of the three PCs’ loadings derived from PCA applied to the Raman map of a plaque 
(figure 3e–h). The plots are labelled based on the structures they represent: PC1-mean spectrum of 
the tissue, PC2-ring, and PC3-core. The main resonances in these plots are also reported. Notable 
differences characterize the amide I region, with the core exhibiting a symmetric intense peak at 1667 
cm–1 due to -pleated sheet 15, and the ring showing signatures of lipids and other protein 
conformations, e.g. -helix 20. 
 
Cellular and functional correlates. To elucidate the origin of the lipid ring around the amyloid plaque 
core detected by FTIR imaging and Raman microscopy, we performed a second subset of experiments 
using amylo-glo and immunofluorescent co-labelling with antibodies for astroglia (GFAP). These cell 
types have previously been reported to cluster around plaques 24-28. 
 
To establish if there was a link between the astrocyte processes and the lipid ring, we compared the 
ratio of the diameter of the plaque core to the width of the lipid ring for a number of plaques in both 
the immunofluorescent, FTIR and Raman images. An example of this measurement can be seen in 
Figure 4, with a Raman image of a plaque alongside an immunofluorescence image. Using the ratio of 
plaque core to lipid ring provided a robust relative measure that could be used on a number of 
different sized plaques, in different samples. We obtained a ratio of 0.45 ± 0.05 (N=30 plaques) for all 
plaques visualised by FTIR, Raman and immunofluorescence. As the lipid ring has approximately the 
same width as the astrocyte processes, and they co-localise in the same position about the plaque 
core, we conclude that this is compelling evidence that the lipid ring is associated with the astrocyte 
processes. 
 
More examples of immunostained plaques can be seen (figure SI-4) which reveal that astrocytes 
cluster around the vast majority of the plaques and have cell bodies located in the outer rim of the 
cluster while radially projecting processes (i.e. membrane extensions) towards the plaque core. This 
is a feature of astrogliosis in the brain parenchyma. 
 
Interestingly, we also show how Raman has the spatial resolution to detect cell bodies. In figure SI-3c, 
the Raman map shows cell bodies in the region surrounding the lipid-rich halo of the plaque that are 
revealed as small ovoids of ca. 10 m diameter (yellow in the pseudo-colour map). The presence of 
nearby cell bodies has previously been revealed by synchrotron-based FTIR imaging but not by globar 
source FTIR 12, suggesting that high spatial resolution is a requirement for (unlabelled) detection of 
these small features. The Raman maps presented here give high definition for the cell bodies and 
comparable spatial resolution to the synchrotron FTIR images. Similar cell bodies can also be seen in 
immunofluorescent images (figure 4d). 
 
 
Figure 4. (Top panel) Self-organising map principal component analysis (SOM PCA) results derived from a Raman map of a 
plaque in a transgenic mouse brain hippocampal section. The Raman map was acquired over a 92⨉92 m2 area using a 1.4 
m step-size. Map scores refer to the distribution of the (a) SOM PC1, which denotes the -sheet core of the plaque, and (b) 
SOM PC2, showing the lipid halo surrounding the plaque core. Corresponding loading plots are shown in figure SI-3. (Bottom 
panel) Immunofluorescence images at 20⨉ magnification of a large plaque within a section of TG mice brain containing the 
hippocampus stained with (c) amylo-glo for A peptide and (d) GFAP for astroglia. The plaque represented in a) and b) is 
different from the one in c) and d). Arrows indicate the location of processes and cell bodies. Segments denote the size of 
the plaque core and lipid ring, providing a measure of the lipid ring width-to-plaque core diameter of approximately 0.5 in 
both types of images. 
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Discussion 
 
The chemical structure and formation of amyloid plaques is a much studied, but still controversial 
topic. Here we have used spectroscopic tools to chemically analyse plaques in situ, in combination 
with conventional fluorescence stains to visualise plaques and surrounding biological processes. Our 
results are consistent with the hypothesis that a lipid-ring, which is seen surrounding many plaques, 
is associated with astrocyte processes. This is evidenced by immunohistochemistry images that show 
astrocyte processes surrounding plaques (stained with amylo-glo) and co-localising with the lipid ring. 
 
FTIR imaging and Raman micro-spectroscopy were applied to study the chemical composition of A 
plaques in the hippocampal CA1 region of the brain of TASTPM mice, an A-overexpressing transgenic 
mouse line. Previous studies have used FTIR imaging for the visualization of amyloid plaques and 
have found lipid rings surrounding some plaques 21, 29. However, this is the first time that both FTIR 
imaging and Raman microscopy were applied through a site-matched approach in order to fully 
describe the structure and composition of these plaques. We observed changes in plaque composition 
between the core and the periphery (ring, or shell if considered in 3-D). The core appeared to be richer 
in ordered (intermolecular -pleated sheet) structures, the concentration of which tends to 
progressively decrease from the core through to the periphery of the plaque; on the other hand, lipids 
appeared to be less concentrated in the core of the plaque, instead forming a ring-shaped distribution 
co-localized with less ordered protein structures. The progressive reduction of -pleated sheet 
structures from the core to the periphery of the plaque was confirmed through Raman maps (with NIR 
830 nm excitation). 
 
Fluorescent labelling for A peptide and astrocytes confirmed that some plaques are clustered with 
astrocytes; this is paralleled by the observation that some plaques have a lipid-rich layer around the 
core (detected by FTIR imaging and Raman mapping). Raman maps elucidate the finer details of the 
plaque structure, revealing small ovoids in the outer rim of the plaque that correspond to the cell 
bodies of astrocytes. Astrocytic processes radially extend from the cell bodies towards the core of the 
plaque, co-localizing with the lipid-loaded ring. As for equal volumes the surface/volume ratio 
(approximately corresponding to the lipid/water ratio in cells) is higher in elongated processes 
compared to ovoids, we infer that the astrocytic processes surrounding the plaques likely correspond 
to the origin of the lipid signal detected in this region. This is an important observation, as it reveals 
that the ring around the plaque can itself be a marker of astrogliosis. It should be highlighted that the 
lipid signal may also originate from the activated microglia surrounding Aβ plaques 30; however, 
astrocytes are more likely, as activated microglia are less ramified compared to non-activated 
microglia 31, 32. 
 
As with microglia activation, astrogliosis is strongly associated with amyloidopathy. Several lines of 
evidence suggest that while the amyloid-dependent microglial activation is responsible for increased 
risk and more severe progression of AD 30, 33, amyloid plaque-associated astrogliosis is negatively 
correlated to AD development 24. Post-mortem studies of the brain of people with Alzheimer’s disease 
and non-demented age-matched controls have shown that amyloid plaques can also be found in the 
brain of non-demented controls, especially older people 34, 35, suggesting that other factors might 
promote the pathogenesis and progression of the disease. Also, a recent study has shown that patients 
with lower mini mental state exam (MMSE) scores have a lower astrogliosis-associated plaque burden, 
suggesting that astrogliosis might have a protective role limiting the development of amyloidosis-
dependent dementia 24. 
 
The ability of FTIR imaging and Raman microscopy to detect both Aβ plaques and plaque-associated 
astrogliosis might allow the use of chemical imaging to identify astrogliosis and clustered inflammation 
in nerve tissue with amyloidosis, with potential for translation into an early diagnostic tool. The 
biochemical information this brings will likely prove invaluable for further elucidating the mechanisms 
of AD. 
 
 
Conclusions 
 
In this paper, we have focussed on analysing the chemical composition of plaques in a transgenic 
mouse model of Alzheimer’s disease, using FTIR imaging and Raman microscopy, with correlative 
immunofluorescence imaging. We have found that the plaques tend to have a protein-rich core, high 
in intermolecular -sheets, surrounded by a lipid ring. This ring correlates with processes from 
astrocytes (and possibly microglial cells), which we propose are the origin of the lipid-rich ring found 
in FTIR images and Raman maps. This is a novel finding and adds weight to the hypothesis that 
plaques cause chronic inflammatory responses to the surrounding tissue, which could potentially be 
a root cause of neurodegeneration. 
 
 
Methods 
 
Animal procedures. Animal procedures complied with the UK Home Office Guidelines and the 
University of Exeter Animal Welfare Ethical Review Board. Male 12 months old A-overexpressing 
TASTPM (transgenic, TG) mice and age-matched littermate controls (wild type, WT) were used in this 
study. TASTPM mice carry two mutations on the gene for the amyloid precursor protein (APPSwe 
K670N, M671L) and one on the presenilin 1 gene (M146V) that can be found in patients affected by 
familial Alzheimer’s disease 16, 17. All animals were housed at room temperature under a 12 hour light 
cycle, and fed a normal diet with free access to food and water ad libitum before being sacrificed 36. 
 
Tissue collection and sectioning. The animals were humanely sacrificed by cervical dislocation 
(Schedule 1, ASPA, 1986). The brain was rapidly removed and acute horizontal slices of 300 μm 
thickness were cut in a vibratome and suspended in artificial cerebrospinal fluid, as previously 
described 36. The major part of each brain was used for electrophysiological recordings. A number of 
slices of each brain (TASTPM and WT mice) containing ventral hippocampus, striatum and cortex were 
retained for the present study. The slices were post-fixed overnight with 4% formalin + 0.1 M 
phosphate buffer solution (PBS). They were rinsed twice (5 min each time) with 0.1 M PBS and stored 
in 30% (w/v) sucrose solution to inhibit subsequent formation of ice crystals, before being embedded 
in a water-soluble frozen section medium (NEG-50, Thermo Scientific) and snap frozen. Sections of 20 
μm thickness were cut in a cryostat and left to rinse for at least 24 hours in 0.1 M PBS. Sections were 
subsequently rinsed in distilled water and mounted on Raman-grade polished calcium fluoride slides 
(Crystran, Poole, Dorset, UK). 
 
Microscopy and spectroscopy. Three brain sections per animal (five TASTPM and five WT mice) were 
analysed giving a total of 30 specimens. For two random sections, measurements were rerun to assess 
their repeatability. 
Micro-transmission Fourier transform infrared (FTIR) images were collected with an imaging system 
consisting of an Agilent Technologies Cary 670 FTIR spectrometer coupled to a Cary 620 FTIR 
microscope with a 0.62 NA, 15⨉ Cassegrain objective, and a liquid nitrogen-cooled focal plane array 
(FPA) detector. The detector had 16384 pixels arranged in a 128⨉128 array. The area imaged in 
transmission mode through the 15⨉ objective corresponds to 704⨉704 m2. Characteristic bands 
of proteins and lipids, principally amide I, amide II, ester carbonyl and CH stretching, were analysed, 
yielding images with a spatial resolution in the range of 5–10 m (fingerprint region). These bands 
constitute the spectral signatures of the main components of amyloid plaques.11 Resolutions Pro v. 
5.3 software was used for acquisition and manipulation of the data. An IR absorption spectrum was 
obtained for each detector pixel by co-adding 32 interferograms and applying a Fourier transform. The 
Blackmann-Harris 4-point apodization function was used. Spectra were measured over the range 
4000–1000 cm–1 at a spectral resolution of 4 cm–1 with a zero filling factor of 2, achieving a spectral 
spacing of approximately 2 cm–1. Prior to all image measurements, a background obtained from a 
tissue-free region of the substrate was measured by co-adding 64 interferograms. Large images of the 
whole hippocampus were constructed as mosaics of individual tiles; each tile was selected to be 
128⨉128 pixels. 
FTIR imaging data are hyperspectral datasets, with two spatial dimensions and a third spectral 
dimension (wavenumber); each value in the datasets is absorbance of the sample at each combination 
of position and wavenumber. Absorbance is related to concentration of a chemical constituent 
through the Beer-Lambert law, thus enabling label-free compositional analysis. In the present work, 
the whole mid-infrared spectrum between 4000 and 1000 cm–1, containing the absorption bands of 
proteins and lipids, was measured for each detector pixel. To calculate the absorbance of each band, 
a linear baseline was drawn between the minima either side of the peak and absorbance values above 
this line were integrated with respect to wavenumber. This enabled chemical images to be obtained 
(univariate analysis). 
Raman micro-spectroscopy maps were collected with a Renishaw inVia Raman microscope equipped 
with an 830 nm laser and a Leica long working distance 50⨉ (NA 0.50) objective. The backscattered 
light from the sample was dispersed through a 600 gr/mm grating onto a Renishaw deep depletion 
CCD camera. The spectral resolution was approximately 7 cm–1. Raman maps were acquired in 
streamline mode with an exposure time of 55 s per laser line (equivalent to ca. 9 s per point) with step 
size of 1.4 m, in the range 2400–450 cm–1. WiRE v. 4.0 software was used for acquisition and 
manipulation of the data. Accurate calibration of the set-up and focus adjustment of the objective was 
performed before each series of measurements. Spectra were collected with the focus position 8 m 
into the specimen. Cosmic ray removal was applied to each spectrum using the nearest neighbour 
method. Spectral maps were then analysed by Principal Component Analysis (PCA) using 10 
components and spectrum centring + normalization (SNV) pre-processing. In this manner, the first 
principal component (PC1) corresponds to the average spectrum of the sample. Results were reported 
as obtained, without any further modification including baseline correction. 
Alternatively, when analysing the Raman maps using SOMs the cosmic rays were removed by the 
following method: cosmic rays were filtered from the Raman maps by applying a 3×3 window two-
dimensional median filter to each wavenumber. For the 3×3 window used, the centre pixel for that 
wavenumber is replaced with the median value of all pixels in the window for that wavenumber. After 
the application of median filtering to each wavenumber, the collected Raman spectra were unfolded 
to create a large, two-dimensional data matrix where each row corresponds to the Raman spectrum 
of a single pixel and each column to a single wavenumber. At this stage the spectra were compressed 
using the Self Organising Maps (SOM) algorithm (as described in ref 37), followed by extended 
multiplicative scatter correction, mean centring and then PCA. 
The tissue samples analysed by FTIR imaging and Raman microscopy were subsequently stained with 
amylo-glo reagent (Biosensis), mounted with fluoromount (Sigma) and imaged on a Nikon Eclipse EF-
800 epifluorescence microscope. Staining was performed as previously reported 19; see also the 
Supplementary Information for a detailed description of amylo-glo staining of A plaques. To clarify 
the origin of the lipid signature in the region surrounding the plaque core in FTIR images of TASTPM 
mouse hippocampus, slices were immunohistochemically stained for astroglia and co-stained with 
amylo-glo to check the pattern of distribution of astrocytes with respect to the A plaque cores. See 
SI for a detailed description of the immunohistochemical procedures. All images were taken with an 
epifluorescence microscope. 
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